Helicobacter (H.) suis causes gastric lesions in pigs and humans. This study aimed to evaluate 15 the protective efficacy of immunization with combinations of the H. suis urease subunit B (UreB) 16 and γ-glutamyl transpeptidase (GGT), both recombinantly expressed in Escherichia coli (rUreB 17 and rGGT, respectively). Mice were intranasally immunized with rUreB, rGGT or a combination 18 of both proteins, administered simultaneously or sequentially. 
Introduction 36
Helicobacter (H.) suis is a worldwide spread bacterium causing chronic gastritis and reduced 37 daily weight gain in pigs [1] . An infection with H. suis has also been associated with erosive and 38 ulcerative lesions in the non-glandular part of the porcine stomach [2, 3] . Furthermore, this 39 bacterium is the most prevalent non-H. pylori Helicobacter species colonizing the stomach of 40 humans suffering from gastric disease [4] . Previous studies in mice have shown that prophylactic 41 intranasal immunization with H. suis whole-cell lysate results in significant protection against H. 42 suis infections [5, 6] . However, production of sufficient H. suis whole-cell lysate may be hindered 43 by the laborious in vitro cultivation of this bacterium. Also, whole-cell lysates may contain both 44 protective antigens and antigens suppressing protection [7] . To overcome these drawbacks, a 45 subunit vaccine, based on the H. suis urease subunit B (UreB) has been developed [6] . 46
Immunization with H. suis UreB, recombinantly expressed in E. coli (rUreB) only induced a 47 One week after the second immunization animals were immunized twice with 3 weeks interval 127 with 30 µg rUreB + 5 µg CT. Three weeks after the last immunization, blood was collected by 128 tail bleeding from 5 animals per group and one week later, all animals, except the negative 129 control group, were intragastrically inoculated 10 8 instructions. The bacterial load in the stomach was determined using a previously described H. 138 suis specific quantitative real-time PCR (qPCR) [13] . 139
Stomach cytokine responses 140
The mRNA expression levels of IFN-γ, TNF-α, IL-4, IL-10 and IL-17 were assessed by RT-141 qPCR using cDNA synthesized from stomach tissue as described previously [14] . The threshold 142 cycle (Ct) values were normalized to the geometric mean of the Ct-values from the reference 143 genes after which normalized mRNA levels were calculated using the 2 -∆ΔCt method [15] . 144
Serum antibody responses 145
Anti-rUreB, -rGGT and -lysate serum immunoglobulin G (IgG) responses were assessed by using 146 the Protein Detector™ enzyme-linked immunosorbent assay (ELISA) Kit (KPL, Gaithersburg 147 MD, USA). Measurement of anti-rUreB, anti-rGGT and -lysate specific serum IgG was 148 performed as previously described [6] . In brief, 96 well flat bottom plates (Nunc MaxiSorp, 149 Nalge Nunc Int., Rochester, NY, USA) were coated with 1 µg/well of purified rUreB, 2 µg/well 150 of purified rGGT, or 1 µg/well of H. suis whole cell proteins diluted in 100 µL coating buffer. 151
After blocking with 1% bovine serum albumin in PBS, 100 µL of 1/400 diluted serum was added 152 to each well. After further washing, 100 µL of HRP-labeled anti-mouse IgG (H+L) in a final 153 concentration of 50 ng per well was added. Absorbance was read at 405nm (OD 405nm Software Inc., San Diego, CA) was used for all analyses. Statistically significant differences 175 between groups were considered at p < 0.05. 176 inflammation scores were observed in the fundus compared to the antrum (Fig 5A and B) . All 236 negative controls had a normal gastric histomorphology (score 0) and sham-immunized, infected 237 mice showed a weak gastric infiltration of mononuclear and/or polymorphonuclear cells (Fig 5C, In a recent study, we demonstrated that intranasal vaccination with rUreB alone resulted in a 274 significant reduction of gastric H. suis colonization, although complete protection was not 275 achieved [6] . Therefore, the present study aimed to evaluate whether a combination of rUreB and 276 rGGT could increase the vaccine efficacy. H. suis GGT is a secreted virulence factor that acts in a 277 similar way as the H. pylori GGT. The enzyme causes a glutathione degradation-dependent 278 epithelial cell death [10, 17] . In addition, it inhibits the proliferation of T-cells and thus may 279 prevent the generation of an effective host immune response [8, 18] . 
Results 177
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